Your browser doesn't support javascript.
loading
Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy.
Liu, Zaoqu; Li, Huanyun; Dang, Qin; Weng, Siyuan; Duo, Mengjie; Lv, Jinxiang; Han, Xinwei.
Afiliação
  • Liu Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Li H; Interventional Institute of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Dang Q; Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, 450052, Henan, China.
  • Weng S; Genetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Duo M; Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Lv J; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Han X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Cell Mol Life Sci ; 79(11): 577, 2022 Oct 31.
Article em En | MEDLINE | ID: mdl-36316529
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteômica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Cell Mol Life Sci Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteômica / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Cell Mol Life Sci Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China